Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032

The global pharmaceutical manufacturing equipment market size is projected to be USD 21.24 billion in 2026 and USD 30.39 billion by 2032, registering a CAGR of 6.2% during the forecast period. The market is progressing steadily due to the rising demand for efficient and compliant drug production systems. Pharmaceutical companies are expanding production capacity to meet growing medicine demand. Process accuracy and product quality remain key priorities. Regulatory compliance requirements drive the modernization of production lines. Increasing demand for generic drugs and biologics supports scalable manufacturing solutions. Strict quality standards require validated and reliable equipment. Investment in pharmaceutical infrastructure continues to rise. These factors support the adoption of advanced manufacturing equipment across global pharmaceutical facilities.

“Packaging machines segment is anticipated to grow at the fastest CAGR from 2026 to 2032”

Packing machines are expected to record the highest CAGR during the forecast period due to the growing emphasis on safe and compliant pharmaceutical packaging. Pharmaceutical companies are prioritizing product protection and shelf life extension. Strict regulatory requirements are increasing investment in advanced packaging systems. The growing production of tablets and capsules is raising packaging volumes. Injectable drugs also require secure handling. Demand for tamper-proof packaging is increasing. Additionally, the increasing adoption of automation and serialization technologies to ensure traceability and reduce counterfeiting risks is further accelerating the demand for advanced packaging machines across pharmaceutical manufacturing facilities.

“Liquid segment is expected to dominate the pharmaceutical manufacturing equipment market during the forecast period”

The liquid segment is expected to account for the largest market share during the forecast period due to the mounting demand for injectables and biologics. Vaccines and oral liquid medicines are also driving production growth. The increasing prevalence of chronic diseases supports the higher output of sterile formulations. Expansion of immunization programs strengthens demand across regions. Pharmaceutical companies are investing in advanced filling and sealing systems. Growth in contract manufacturing supports capacity expansion. Patient preference for easy administration is increasing the adoption of liquid forms. This shift supports higher capital investment in liquid manufacturing infrastructure globally.

“China held the largest share of the Asia Pacific pharmaceutical manufacturing equipment market in 2025”

China accounted for the largest share of the pharmaceutical manufacturing equipment market during the forecast period due to its large-scale production capacity. The country maintains a strong position in active pharmaceutical ingredient (API) and generic drug manufacturing. A wide base of facilities ranges from small domestic producers to export-focused companies. Many plants operate advanced automated production lines. Investment in biologics and vaccines is increasing equipment demand. Sterile manufacturing expansion supports process system upgrades in the country. Contract manufacturing growth drives additional capacity additions, while facility modernization to meet international regulatory standards strengthens demand. These compliance requirements encourage the adoption of validated systems. These factors position it as the leading market for pharmaceutical manufacturing equipment.

• By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%
• By Designation: Directors – 40%, C-level Executives – 45%, and Others – 15%
• By Region: North America – 26%, Europe – 28%, Asia Pacific – 41%, and RoW – 5%

Prominent players profiled in this report include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), Körber AG (Germany), Coperion GmbH (Germany), Romaco Group (Germany), Marchesini Group S.p.A (Italy), and Bausch+Ströbel SE + Co. KG (Germany).

Research Coverage

The report defines, describes, and forecasts the pharmaceutical manufacturing equipment market based on equipment type (packaging machines, filling machines, spray drying equipment, mixing & blending machines, milling equipment, extrusion equipment, tablet compression presses, inspection equipment, granulation equipment, and sterilization equipment), end-product type (solid and liquid), and technology (semi-automatic and automatic). It also analyzes the market across key regions, including North America, Europe, Asia Pacific, and RoW. The report provides detailed insights into the major drivers, restraints, opportunities, and challenges influencing market growth. In addition, it evaluates competitive developments, such as product launches, expansions, partnerships, acquisitions, and strategic initiatives undertaken by leading companies to strengthen their market position.

Reasons to Buy This Report

The report will help market leaders/new entrants with information on the closest approximations of the revenue for the overall pharmaceutical manufacturing equipment market and its subsegments. The report will help stakeholders understand the competitive landscape and gain more insight to position their business better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market’s pulse and provides information on key drivers, restraints, opportunities, and challenges.

The report will provide insights into the following points:

• Analysis of Key Drivers (Increasing commercialization of biologics and complex formulations, Growing preference for personalized medicines and targeted therapies, Rapid advances in automation, digital monitoring, and Industry 4.0 technologies, Escalating generic drug production), restraints (High capital expenditure requirements, Issues related to integration with existing systems, Implementation of stringent regulatory compliance standards), opportunities (Expansion of contract development and manufacturing organizations, Mounting demand for sterile and aseptic injectable drugs, Rising integration of advanced inspection and serialization technologies), and challenges (Requirement for frequent technological upgrades, Complex validation and revalidation cycles, Technical and operational challenges related to small-batch production) of the pharmaceutical manufacturing equipment market.
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product launches in the pharmaceutical manufacturing equipment market
• Market Development: Comprehensive information about lucrative markets (the report analyzes the pharmaceutical manufacturing equipment market across various regions)
• Market Diversification: Exhaustive information about new product launches, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and offering of leading players, including GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc (US) in the pharmaceutical manufacturing equipment market

Show more